The expression of PSMA, a marker of neovasculature formation [10, 11], has been reported to be related to tumor recurrence in TC [8, 12]; while high [18F]FDG uptake, a marker of less differentiated thyroid tumors [13], indicates poorer prognosis [4, 14]. This evidence concerns the gene FOLH1 and thyroid tumor.